SCHEMBL21933045

SCHEMBL21933045

COc1cccc(Nc2nc3ccccc3c3onc(N)c23)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 11/20 0.56
MEN1 O00255 6/20 0.56
KMT2A Q03164 6/20 0.56
ABCB1 P08183 6/20 0.55
PDE5A O76074 1/20 0.55
DYRK3 O43781 1/20 0.53
MAP4K4 O95819 1/20 0.53
EGFR P00533 1/20 0.53
PDGFRA P16234 1/20 0.53
LTK P29376 1/20 0.53
GRK5 P34947 1/20 0.53
KDR P35968 1/20 0.53
MAPK8 P45983 1/20 0.53
CDK8 P49336 1/20 0.53
CDK7 P50613 1/20 0.53
IRAK1 P51617 1/20 0.53
NEK4 P51957 1/20 0.53
LIMK1 P53667 1/20 0.53
ACVR1 Q04771 1/20 0.53
TNK2 Q07912 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21933040 0.87 NPY5R (0.54) ABCG2MEN1KMT2AABCB1HTT
SCHEMBL21933042 0.84 ALOX15 (0.48) ABCG2MEN1KMT2APDE5AMAP4K4
SCHEMBL21933046 0.82 POLB (0.56) MEN1KMT2AHTTLMNANPC1
SCHEMBL21933022 0.81 POLB (0.53) ABCG2MEN1KMT2AEGFRHTT
SCHEMBL21933016 0.81 MEN1 (0.57) ABCG2MEN1KMT2APDE5ALMNA
SCHEMBL18264403 0.79 BTK (0.57) ABCG2MEN1KMT2AABCB1PDE5A
SCHEMBL21933015 0.79 NPY5R (0.51) ABCG2MEN1KMT2ACLK4HTT
SCHEMBL21933029 0.79 ABCG2 (0.52) ABCG2MEN1KMT2APDE5AEGFR
SCHEMBL21933034 0.78 ABCG2 (0.54) ABCG2MEN1KMT2AABCB1PDE5A
SCHEMBL2301864 0.78 KDM4E (0.59) ABCG2MEN1KMT2AABCB1PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3876933-B1 NEUTROPHIL INFLAMMATION INHIBITOR AND USES THEREOF UNIV CHANG GUNG SCIENCE & TECHNOLOGY (TW) 2023-09-13 EP disclosed
US-10654848-B1 Neutrophil inflammation inhibitor and uses thereof CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2020-05-19 US disclosed
US-20200148674-A1 NEUTROPHIL INFLAMMATION INHIBITOR AND USES THEREOF CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10654848-B1 Neutrophil inflammation inhibitor and uses thereof SERPINB1, SERPINE1, MMP8 ABCG2 3661/4885MEN1 4107/4885KMT2A 4847/4885
US-20200148674-A1 NEUTROPHIL INFLAMMATION INHIBITOR AND USES THEREOF SERPINB1, SERPINE1, MMP8 ABCG2 3661/4885MEN1 4107/4885KMT2A 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.